日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial

不可切除肝细胞癌患者接受 tremelimumab 联合 durvalumab 治疗和 durvalumab 单药治疗的免疫介导不良事件和总生存期:HIMALAYA III 期随机临床试验

Lau, George; Sangro, Bruno; Cheng, Ann-Lii; Kudo, Masatoshi; Kelley, Robin Kate; Tak, Won Young; Gasbarrini, Antonio; Reig, Maria; Lim, Ho Yeong; Tougeron, David; De Toni, Enrico N; Tam, Vincent C; Mody, Kabir; Gong, Jun; Crysler, Oxana V; Sukeepaisarnjaroen, Wattana; Lipatov, Oleg; Morimoto, Manabu; Archambeaud, Isabelle; Burgio, Valentina; Phuong, Le Thi Tuyet; Chao, Yee; Peron, Jean-Marie; Berres, Marie-Luise; Ko, Yoo-Joung; Ran, Di; Makowsky, Mallory; Negro, Alejandra; Abou-Alfa, Ghassan K

Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation

免疫疗法与乐伐替尼治疗晚期肝细胞癌的疗效比较:基于目标试验模拟的真实世界分析

Ahn, Joseph C; Ng, Wee Han; Yeo, Yee Hui; Kim, Hyun-Seok; Wang, Yun; Trivedi, Hirsh; Ayoub, Walid S; Kuo, Alexander; Rich, Nicole; Parikh, Neehar D; Abou-Alfa, Ghassan K; Ma, Kevin Sheng-Kai; Singal, Amit G; Yang, Ju Dong

MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response

MAPK通路突变出现在对IDH1抑制剂耐药的胆管癌中,并减弱IFN反应

Wan, Jinkai; Saatcioglu, Hatice Duygu; Ellis, Haley; Aguado-Fraile, Elia; Xu, Qin; Kondo, Hiroshi; Manguso, Robert T; Gritti, Ilaria; Norden, Bryanna L; Noble, Carolina; Corcoran, Ryan B; Lubner, Sam J; Javle, Milind; Abou-Alfa, Ghassan K; Cleary, James M; Kelley, Robin K; Borad, Mitesh J; Macarulla, Teresa; Oh, Do Youn; Daigle, Scott; Gliser, Camelia; Pandya, Susan; Choe, Sung; Tron, Adriana E; Bardeesy, Nabeel

Systematic cell-type resolved transcriptomes of 8 tissues in 8 lab and wild-derived mouse strains capture global and local expression variation

对8个实验室和野生小鼠品系的8种组织进行系统性的细胞类型解析转录组分析,揭示了整体和局部表达变异。

Rebboah, Elisabeth; Weber, Ryan; Abdollahzadeh, Elnaz; Swarna, Nikhila; Sullivan, Delaney K; Trout, Diane; Reese, Fairlie; Liang, Heidi Yahan; Filimban, Ghassan; Mahdipoor, Parvin; Duffield, Margaret; Mojaverzargar, Romina; Taghizadeh, Erisa; Fattahi, Negar; Mojgani, Negar; Zhang, Haoran; Loving, Rebekah K; Carilli, Maria; Booeshaghi, A Sina; Kawauchi, Shimako; Hallgrímsdóttir, Ingileif B; Williams, Brian A; MacGregor, Grant R; Pachter, Lior; Wold, Barbara J; Mortazavi, Ali

IL-10R inhibition induces neutrophil tumoricidal activity.

IL-10R抑制可诱导中性粒细胞的杀瘤活性。

Khalil Danny N, Gomez Ricardo, Regev Amit, Samaan Fadi, Marouf Yacine, Budhu Sadna, Hirschhorn Daniel, Schulze Isabell, Lavery Jessica A, Ceglia Nicholas, Freeman Samuel S, Maltez Vivien I, Garcia Jaynia M, Suek Nathan, Weng Chien-Huan, Cabanski Christopher R, Monette Sebastien, Romin Yevgeniy, Li Yanyun, Chaligne Ronan, Yellin Michael J, Keler Tibor, Maurer Deena M, Flamar Anne-Laure, Morgado-Palacin Lucia, Mangarin Levi M, Harding James J, Park Wungki, Lyman Jaclyn P, Maddock Stephen, O'Hara Mark H, Abou-Alfa Ghassan K, Vonderheide Robert H, O'Reilly Eileen M, Germain Ronald N, Wolchok Jedd D, Merghoub Taha

What makes an intervention dyadic? Introducing the DYADIC meta-framework to Describe Your focAl Dyadic Intervention Components

什么使干预措施具有二元性?引入 DYADIC 元框架来描述您关注的二元干预措施的组成部分

Tafreshi, Narges K; Pandya, Darpan N; Tichacek, Christopher J; Budzevich, Mikalai M; Wang, Zhen; Reff, Jordan N; Engelman, Robert W; Boulware, David C; Chiappori, Alberto A; Strosberg, Jonathan R; Ji, Haitao; Wadas, Thaddeus J; El-Haddad, Ghassan; Morse, David L; Berli, Corina; Scholz, Urte; Allen, James M; Di Maio, Sally; Höhener, Patrick S; Knoll, Nina; Luszczynska, Aleksandra; Nakamura, Monique S; Simpson, Jeffry A; Stadler, Gertraud; Villinger, Karoline; Wilhelm, Lea O; Rothman, Alexander J

Immune-Related Adverse Events Are Associated With Improved Outcomes After Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

免疫相关不良事件与肝细胞癌免疫检查点抑制剂治疗后预后改善相关:系统评价和荟萃分析

Hwang, Soo Young; Rezaee-Zavareh, Mohammad Saeid; Attia, Abdelrahman M; Kaymen, Emily A; Tran, Nguyen; Abou-Alfa, Ghassan K; Parikh, Neehar D; Singal, Amit G; Yang, Ju Dong

Practice changing RCT design and rationale: Abbreviated MRI plus AFP vs. ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study)

改变实践的 RCT 设计和原理:简化的 MRI 加 AFP 与超声加 AFP 用于肝硬化 HCC 监测的比较(PREMIUM 研究)

Ioannou, George N; Taddei, Tamar H; Planeta, Beata M; Huang, Grant D; Weiss, Noel S; Morgan, Timothy R; Dominitz, Jason A; Abou-Alfa, Ghassan K; Bashir, Mustafa R; Beheshti, Michael V; Singal, Amit G; Moylan, Cynthia A; Boland, Robin J; Buchwalder, Lynn F; Mehta, Rajni L; Hoisington, Kimberly S; Do, Nhan V; Rogal, Shari S; Kaplan, David E; Benhammou, Jihane N; Su, Grace L; McDonald, Linda M; Dani, Genta; Dunn, Dell P; Chang, Stephanie T; Onyiuke, Ifeyinwa Y; Sharma, Ashu; Kyriakides, Tassos C

Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study

四价脑膜炎球菌结合疫苗(MenACYW-TT)在年龄≥56岁的潜在朝觐/副朝朝圣者中的免疫原性和安全性:一项III期开放标签研究

Dbaibo, Ghassan S; Balik, Ismail; Akdemir, İrem; Buzgan, Turan; Guner, Rahmet; Boutros, Celina F; Damaj, Stephanie; Zein, Zeinab El; Merhi, Sarah; Faour, Kawthar; Tfaily, Nadim; Khafaja, Sarah; Dogu, Alp; Ceyhan, Mehmet

N-Benzyl-6-Chloro-4-Hydroxy-2-Quinolone-3-Carboxamides: Synthesis, Computational Studies, and Biological Investigation as Anticancer Agents

N-苄基-6-氯-4-羟基-2-喹诺酮-3-甲酰胺:合成、计算研究及作为抗癌剂的生物学研究

Meknas, Sara Jamal; Al-Shalabi, Eveen; Hajjo, Rima; Bardaweel, Sanaa K; Abushaikha, Ghassan; Sweidan, Kamal; Balaji, Swapnaa; Tiwari, Amit K; Zhong, Haizhen A; Sabbah, Dima A